Bio-Rad Laboratories, Inc.
BIO· NYSE
BIOBio-Rad Laboratories, Inc.
Filed Aug 4, 2023 · 10-Q · 35 days after period end · 0000012208-23-000063
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $681.11M | $691.10M | $715.93M | $536.88M |
| Net Income | -$1.16B | -$925.10M | $916.80M | $966.40M |
| EPS Diluted | -$39.59 | -$31.05 | $30.41 | $32.15 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Aug 4, 2023 · 35 d after period end
